MIRACLE - art photonics

Latest News

22 March 2023

Insights from our CEO: Interview with Laser Focus World

By Stanislav Perevoschikov

Are you curious about the revolutionary ways in which our custom fiber solutions are helping surgeons fight cancer and scientists discover new exoplanets? Our CEO, Viacheslav Artyushenko, shares insights into the limitless potential of our cutting-edge PIR- & CIR-fiber products in his latest interview. Join the likes of the European Space Agency and oncology surgeons […]

16 March 2023

Revolutionize Cancer Diagnosis with Quantum Entangled Photons

By Stanislav Perevoschikov

art photonics is proud to be a part of the Quantum-Enhanced Early Diagnostics (QEED) project, which aims to revolutionize cancer diagnosis and treatment by developing a novel imaging technique based on quantum entangled photon pairs. This technology, known as QEED microscopy, will enable label-free examination of tissue samples in just two minutes, significantly reducing measurement […]

Latest Events

17 March 2023

CPAC Rome | 20-22 March, 2023

By Stanislav Perevoschikov

We are thrilled to announce that Dr. Viacheslav Artyushenko, President of art photonics GmbH, will be presenting at the upcoming CPAC Workshop in Rome on March 20th. Dr. Artyushenko's presentation, titled "Fiber Spectroscopy Solutions for Remote Process-Control in-line", will focus on the application of fiber optic technology in process analytical technology (PAT) for remote process […]

21 February 2023

Meet us at ISLOP 2023

By Stanislav Perevoschikov

Join the top researchers, scientists, and scholars in Lasers, Optics & Photonics at ISLOP2023, a three-day conference for exchanging ideas, presenting sophisticated research, and discussing hot topics in the field. Meet and network with like-minded professionals and gain valuable insights from industry leaders, including Viacheslav Artyushenko, CEO of art photonics GmbH, who will be the […]

MIRACLE: Mid-infrared arthroscopy innovative imaging system for real-time clinical in depth examination and diagnosis of degenerative joint diseases

MIRACLE will push towards commercialisation the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage enabling early diagnosis of degenerative joint diseases such as osteoarthritis (OA). The proposed device is intended for use during arthroscopy, a minimally invasive surgery. Currently, the surgeon’s decision-making is based on visual inspection and manual probing of the cartilage tissue which is highly subjective and of poor repeatability. MIRACLE concept is to assess changes to the biochemical composition of articular cartilage, which precede OA. This will be achieved combining three novel photonics components: (i) a quantum cascade laser array tailored to biodiagnostics, (ii) an on-chip beam combiner for efficient radiation coupling, and (iii) a MIR sensing probe for imaging. These components will be integrated in a medical device to be placed in the arthroscopy market. In addition, to add value to the European medical equipment industry, MIRACLE strives towards cost reduction of OA patients contributing to more affordable public healthcare and promoting well-being in the European ageing population.

art photonics‘ role in joint work will be to develop and provide flexible IR-fibers for quantum cascade lasers (QCL) coupling with the distal end of arthroscopic probe.

The unique polycrystalline fiber technology for 4-16µm range and unique design of ATR-diamond tip will enable efficient and flexible coupling of QCL with detector. This worldwide first prototype of IR-fiber spectral sensor will open the first opportunity to see molecular changes in cartilage composition in-vivo, to link them with its specific decease and find the best way of the related treatment for a fast cartilage recovery.

This project received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 780598. The project is an initiative of the Photonics Public Private Partnership.